MEKICS CO., Ltd
Financials
Valuation Metrics
MEKICS CO., Ltd's Market Cap is ₩246B. At end of 2025 it was ₩303B. Ranked #2222 of 2,421 in KR market (top 92%), #1460 of 1,640 on KOSDAQ (top 89%), #89 of 96 in Health Care Equipment & Services (top 93%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 24.56B KRW | KR#2,222/2,421 Sec#89/96 |
| Revenue | 13.76B KRW | KR#2,232/2,421 Sec#77/96 |
| Net Income | 1.08B KRW | KR#1,474/2,421 Sec#47/96 |
| Total Assets | 56.48B KRW | KR#2,147/2,421 Sec#70/96 |
| Net Assets | 37.41B KRW | KR#2,089/2,421 Sec#73/96 |
| Employees | 106 | KR#1,602/2,421 Sec#55/96 |
| Value | ||
| P/E | 22.78x | KR#1,222/2,421 Sec#39/96 |
| P/B | 0.66x | KR#1,064/2,421 Sec#20/96 |
| P/S | 1.79x | KR#1,738/2,421 Sec#47/96 |
| EV/EBITDA | 71.23x | KR#1,432/2,421 Sec#46/96 |
| FCF Yield | -10.43% | KR—/2,421 Sec—/96 |
| Profitability | ||
| ROE | 2.88% | KR#1,337/2,421 Sec#46/96 |
| ROA | 1.91% | KR#1,236/2,421 Sec#46/96 |
| Op. Margin | 3.71% | KR#1,135/2,421 Sec#42/96 |
| Revenue Growth | 30.23% | KR#392/2,421 Sec#20/96 |
| Financial Health | ||
| Debt Ratio | 50.99% | KR#973/2,421 Sec#56/96 |
| Total Debt | 15.31B KRW | KR#1,490/2,421 Sec#46/96 |
| FCF | -2.56B KRW | KR#1,371/2,421 Sec#44/96 |
| Cash | 3.54B KRW | KR#2,124/2,421 Sec#85/96 |
| Current Ratio | 1.23x | KR#1,477/2,421 Sec#74/96 |
| Net Debt/EBITDA | 23.07x | KR#1,394/2,421 Sec#45/96 |
| Dividend | ||
| Div. Growth | -63.86% | KR—/2,421 Sec—/96 |
| Performance | ||
| 1Y Return | -24.82% | KR#1,399/2,421 Sec#33/96 |
| 1M Return | -14.76% | KR#2,237/2,421 Sec#85/96 |
| From 52W High | -61.75% | KR#1,913/2,421 Sec#65/96 |
| 1Y MDD | -57.89% | KR#1,357/2,421 Sec#46/96 |
| Trading | ||
| Volume | 36,746 shares | KR#1,279/2,421 Sec#45/96 |
| Trading Value | 56.1M KRW | KR#1,794/2,421 Sec#68/96 |
| Foreign Own. | 5.45% | KR#802/2,421 Sec#25/96 |
| Per Share | ||
| EPS | 67 KRW | KR#1,479/2,421 Sec#45/96 |
| BPS | 2,331 KRW | KR#1,998/2,421 Sec#64/96 |
Company Info
Mecics, established in 1998 and listed on KOSDAQ in 2015, designs, manufactures, and sells medical devices such as artificial respirators, respiratory therapy devices, and patient monitoring devices for emergency rooms and intensive care units. The company developed Korea's first artificial respirator, securing international competitiveness. It leads the global market with world-class high-flow respiratory therapy technology and is expanding sales following US FDA approval and Japan PMDA registration. Mecics was established in 1998 and is headquartered in Paju, Gyeonggi-do.